pimecrolimus topical
Selected indexed studies
- Off-label Uses of Topical Pimecrolimus. (J Cutan Med Surg, 2019) [PMID:31053034]
- Topical pimecrolimus for eczema. (Cochrane Database Syst Rev, 2007) [PMID:17943859]
- Topical treatments for atopic dermatitis (eczema): Systematic review and network meta-analysis of randomized trials. (J Allergy Clin Immunol, 2023) [PMID:37678572]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Off-label Uses of Topical Pimecrolimus. (2019) pubmed
- Topical pimecrolimus for eczema. (2007) pubmed
- Topical treatments for atopic dermatitis (eczema): Systematic review and network meta-analysis of randomized trials. (2023) pubmed
- Cancer risk with topical calcineurin inhibitors, pimecrolimus and tacrolimus, for atopic dermatitis: a systematic review and meta-analysis. (2023) pubmed
- Topical pimecrolimus: a review of its use in the management of pediatric atopic dermatitis. (2009) pubmed
- Topical tacrolimus and pimecrolimus and the risk of cancer: how much cause for concern? (2005) pubmed
- Topical pimecrolimus: a review of its clinical potential in the management of atopic dermatitis. (2002) pubmed
- Topical pimecrolimus in the treatment of vitiligo. (2007) pubmed
- Topical therapy of atopic dermatitis with a focus on pimecrolimus. (2021) pubmed
- Pimecrolimus. (2006) pubmed